Abstract
Metachromatic leukodystrophy was first described in adults. Alzheimer (1910) gave a brief abstract of a case which he characterized as a white matter disease with destruction of myelin and abundant, brightly metachromatic deposits in glia cells. Witte (1921) reported similar findings and recognized the accumulation of metachromatic granules in neuronal perikarya and in liver, kidney, gallbladder, anterior pituitary and testes; he suggested that in vivo diagnosis of the disease should be possible from metachromatic material excreted into the urine. Kaltenbach (1922) gave the first detailed description of the histopathology of the white matter lesions. These early descriptions of many of the essential microscopic features of metachromatic leukodystrophy had relatively little impact on its classification in subsequent reports, because the chemistry of metachromasia was not understood, and its significance for the classification of the disease was not realized. Hence, the first descriptions of metachromatic leukodystrophy in infants emphasized other, less specific, criteria such as its familial occurrence, the age of onset or rate of progression, the interpretation of the metachromatic deposits as “prelipoids”, or a high degree of selectivity in the affectation of oligodendroglia. Brain and Greenfield (1950) defined the clinical features of the late infantile course of the disease and deserve the credit for identifying the metachromatic staining of the deposits as the key feature in classifying the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abraham, K., Lampert, P.: Intraneuronal lipid deposits in metachromatic leukodystrophy. Histochemical and topographic observations. Neurology (Minneap.) 13: 686–692, 1963.
Alzheimer, A.: Beiträge zur Kenntnis der pathologischen Neuroglia und ihrer Beziehungen zu den Abbauvorgängen im Nervensystem. Histol. Histopath. Arbt. Großhirnrinde (Nissl, Alzheimer) 3: 401–562, 1910.
Anzil, A. P., Blinzinger, K., Martinus, J.: Ultrastructure of the storage materials in metachromatic leucodystrophy peripheral neuropathy and in rabbit tissues after sulfatide application with special reference to pleated lamellar systems. J. Microscopie 18: 173–186, 1973.
Aurebeck, G., Osterberg, K., Blaw, M., et al.: Electron microscopic observations on metachromatic leucodystrophy. Arch. Neurol. (Chic.) 11: 273–288, 1964.
Austin, J. H.: Metachromatic form of diffuse cerebral sclerosis. II. Diagnosis during life by isolation of metachromatic lipids from urine. Neurology (Minneap.) 7: 716–723, 1957.
Austin, J. H.: Observations in metachromatic leucoencephalopathy. Trans. Amer. neurol. Ass. 83: 149–152, 1958.
Austin, J. H.: Metachromatic form of diffuse sclerosis. III. Significance of sulfatide and other lipid abnormalities in white matter and kidney. Neurology (Minneap.) 10: 470–483, 1960.
Austin, J. H.: Studies in metachromatic leukodystrophy. Arch. Neurol. (Chic.) 28: 258–264, 1973.
Austin, J. H., Balasubramanian, A. S., Pattabiraman, T. N., et al.: A controlled study of enzymic activities in three human disorders of glycolipid metabolism. J. Neurochem. 10: 805–816, 1963.
Austin, J. H., Armstrong, D., Fouch, S., et al.: Metachromatic leukodystrophy (MLD). VII. MLD in adults; diagnosis and pathogenesis. Arch. Neurol. 18: 225–240, 1968.
Austin, J. H., Armstrong, D., Shearer, L.: Metachromatic form of diffuse cerebral sclerosis. V. The nature and significance of low sulfatase activity: A controlled study of brain, liver and kidney in four patients with metachromatic leukodystrophy (MLD). Arch. Neurol. (Chic.) 13: 593–614, 1965.
Austin, J. H., Armstrong, D., Shearer, L., McAfee, D.: Metachromatic form of diffuse cerebral sclerosis. VI. A rapid test for the sulfatase A deficiency in metachromatic leukodystrophy (MLD) in urine. Arch. Neurol (Chic.) 14: 259–269, 1966.
Bass, N. H., Witmer, E. J., Dreifus, F. E.: A pedigree study of metachromatic leukodystrophy. Neurology (Minneap.) 20: 52–62, 1970.
Beratis, N. G., Aron, A. M., Hirschhorn, K.: Metachromatic leukodystrophy: Detection in serum. J. Pediat. 83: 824–826, 1973.
Bischel, M., Austin, J., Kemeny, M.: Metachromatic leukodystrophy (MLD). Arch. Neurol. (Chic.) 15: 13–28, 1966.
Bischoff, A., Ulrich, J.: Amaurotische Idiotie in Verbindung mit metachromatischer Leukodystrophie: Übergangsform oder Kombination? Acta neuropath. (Berl.) 8: 292–308, 1967.
Brain, W. R., Greenfield, J. G.: Late infantile metachromatic leucencephalopathy with primary degeneration of the interfascicular oligodendroglia. Brain 73: 291–317, 1950.
Dayan, A. D.: Peripheral neuropathy of metachromatic leucodystrophy: Observations on segmental demyelination and remyelination and the intracellular distribution of sulphatide. J. Neurol. Neurosurg. Psychiat. 30: 311–318, 1967.
de Silva, K. L., Pearce, J.: Neuropathy of metachromatic leucodystrophy. J. Neurol. Neurosurg. Psychiat. 36: 30–33, 1973.
Greenfield, J. G.: A form of progressive cerebral sclerosis in infants associated with primary degeneration of the interfascicular glia. J. Neurol. Psychopath. 13: 289–302, 1933.
Grégoire, A., Périer, O., Dustin, P.: Metachromatic leucodystrophy, an electron microscopic study. J. Neuropath. exp. Neurol. 25: 617–636, 1966.
Hagberg, B., Sourander, P., Svennerholm, L., Voss, H.: Late infantile metachromatic leucodystrophy of the genetic type. Acta Paediat. 49: 135–153, 1960.
Hagberg, B., Sourander, P., Thorén, L.: Peripheral nerve changes in the diagnosis of metachromatic leucodystrophy. Acta Paediat., Suppl. 135: 63–71, 1962.
Hansson, H.-A., Olsson, Y., Sourander, P.: Experimental studies on the pathogenesis of leucodystrophies. III. Cellular accumulation of injected sulphatides in brain, peripheral nerve and kidney. Acta neuropath. (Berl.) 9: 134–140, 1967.
Harzer, K., Stinshoff, K., Mraz, W., Jatzkewitz, H.: The patterns of arylsulphatases A and B in human normal and metachromatic leucodystrophy tissues and their relationship to the cerebroside sulphatase activity. J. Neurochem. 20: 279–287, 1973.
Helmstaedt, E. R.: Über eine Beobachtung von metachromatischer Leukodystrophie. Dtsch. Z. Nervenkr. 184: 213–234, 1963.
Hirose, G., Bass, N. H.: Adult and late infantile metachromatic leucodystrophy: a comparative biochemical study. Neurology (Minneap.) 21: 443–443, 1971.
Hirsch, T. von, Peiffer, J.: Ober histologische Methoden in der Differentialdiagnose von Leucodystrophien und Lipoidosen. Arch. Psychiat. (Berl.) 194: 88–104, 1955.
Holländer, H.: A staining method for cerebroside sulfuric esters in brain tissue. J. Histochem. Cytochem. 11: 118–119, 1963.
Holländer, H.: Über metachromatische Leukodystrophie. II. Relation zwischen Erkrankungsalter und Verlaufsdauer. Arch. Psychiat. Nervenkr. 205: 300–305, 1964.
Jatzkewitz, H.: Zwei Typen von Cerebrosid-Schwefelsäureestern als sog. „Praelipoide” und Speichersubstanzen bei der Leukodystrophie Typ Scholz (metachromatische Form der Diffusen Sklerose). Hoppe Seyler Z. Physiol. Chem. 311: 279–282, 1958.
Jatzkewitz, H., Pilz, H., Holländer, H.: Biochemische und vergleichende histochemische Untersuchungen in umschriebenen Gebieten des Gehirns bei Fällen von adulter und infantiler metachromatischer Leukodystrophie. Acta neuropath. (Berl.) 4: 75–89, 1964.
Kaback, M. M., Howell, R. R.: Infantile metachromatic leukodystrophy. Heterozygote detection in skin fibroblasts and possible applications to intrauterine diagnosis. New Engl. J. Med. 282: 1336–1340, 1970.
Kaltenbach, H.: Über einen eigenartigen Markprozeß mit metachromatischen Abbauprodukten bei paralyseähnlichem Krankheitsbild. Z. Neurol. Psychiat. 75: 138–146, 1922.
Lison, L.: Etudes sur la métachromasie. Colorants metachromatiques et substances chromotropes. Arch. Biol. (Liege) 46: 599–668, 1935.
Lüthy, F., Ulrich, J., Regli, F., Isler, W.: Amaurotic idiocy with metachromatic change in the white matter? Proc. 5th Internat. Congr. Neuropath. 125–130, Excerpta Medica Foundation, Amsterdam 1966.
Malone, M. J., Conole, J.: Sulfatides and demyelination. Arch. Neurol. (Chic.) 21: 32–43, 1969.
Malone, M. J., Stoifyn, P.: Peripheral nerve glycolipids in metachromatic leukodystrophy. Neurology (Minneap.) 17: 1033–1040, 1967.
Malone, M. J., Stoifyn, P. Moser, H.: Structural studies on sulphatides in metachromatic leucodystrophy. J. Neurochem. 13: 1033–1036, 1966.
Mehl, E., Jatzkewitz, H.: Cerebroside 3-sulfate as a physiological substrate of arylsulfatase A. Biochim. biophys. Acta 151: 619–627, 1968.
Michaelis, L., Granick, S.: Metachromasy of basic dyestuffs. J. Amer. Chem. Soc. 67: 1212–1219, 1945.
Mossakowski, M., Mathieson, G., Cumings, J. N.: On the relationship of metachromatic leucodystrophy and amaurotic idiocy. Brain 84: 585–604, 1961.
Norman, R. M., Urich, H., Tingey, A. H.: Metachromatic leucencephalopathy: A form of lipidosis. Brain 83: 369–380, 1960.
O’Brien, J.: A molecular defect of myelination. Biochem. biophys. Res. Commun. 15: 484–490, 1964.
Pilz, H., Müller, D.: Studies on adult metachromatic leukodystrophy. Part 2. Biochemical aspects of adult cases of metachromatic leukodystrophy. J. Neurol. Sci. 9: 585–595, 1969.
Résibois, A.: Electron microscopic study of metachromatic leucodystrophy. III. Lysosomal nature of the inclusions. Acta neuropath. (Berl.) 13: 149–156, 1969.
Résibois, A.: Electron microscopic studies of metachromatic leucodystrophy. IV. Liver and kidney alterations. Path. Europ. 6: 278–298, 1971.
Résibois-Grégoire, A.: Electron microscopic studies of metachromatic leucodystrophy. II. Compound nature of the inclusions. Acta neuropath. (Berl.) 9: 244–253, 1967.
Stumpf, D., Austin, J.: Metachromatic leucodystrophy. IX. Qualitative and quantitative differences in urinary arylsulfatase A in different forms of MLD. Arch. Neurol. (Chic.) 24: 117–124, 1971.
Stumpf, D., Neuwelt, E., Austin, J., Kohler, P.: Metachromatic leukodystrophy (MLD). X. Immunological studies of the abnormal sulfatase A. Arch. Neurol. (Chic.) 25: 427–431, 1971.
Suzuki, K., Suzuki, K., Chen, G. C.: Isolation and chemical characterization of the metachromatic granules from a brain with metachromatic leukodystrophy. J. Neuropath. exp. Neurol. 26: 537–550, 1967.
Suzuki, K., Suzuki, K., Mizuno, Y.: Juvenile metachromatic leukodystrophy. Deficiency of an arylsulfatase A component. J. Pediat. 85: 823–824, 1974.
Taniguchi, N., Nanba, I.: Enzymatic abnormality of the carrier state in metachromatic leucodystrophy. Clin. chem. Acta 29: 375–379, 1970.
Terry, R. D., Suzuki, K., Weiss, M.: Biopsy study in 3 cases of metachromatic leucodystrophy. J. Neuropath. exp. Neurol. 25: 141–143, 1966.
Thieffry, S., Lyon, G.: Diagnostic d’un cas de leucodystrophic metachromique (type Scholz) par la biopsie d’un nerf périphérique. Rev. Neurol. (Paris) 100: 452–456, 1959.
Thunold, S.: Late infantile metachromatic leucodystrophy. Report of 2 cases and review of in vivo diagnostic tests. Beitr. path. Anat. 146: 322–331, 1972.
Toga, M., Bérard-Badier, M., Pinsard, N., Gambarelli, D., Hassoun, J., Tripier, M. F.: Etude clinique, histologique et ultrastructurale de quatre cas de leucodystrophie métachromatique infantile et juvénile. Acta neuropath. (Berl.) 21: 23–38, 1972.
Webster, H. de F.: Schwann cell alterations in metachromatic leukodystrophy: Preliminary phase and electron microscopic observations. I. Neuropath. exp. Neurol. 21: 534–554, 1962.
Witte, F.: Über pathologische Abbauvorgänge im Zentralnervensystem. Mnch. med. Wschr. 68: 69–69, 1921.
Wolfe, H. J., Pietra, G. G.: The visceral lesions of metachromatic leukodystrophy. Amer. J. Path. 44: 921–930, 1964.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Wien
About this chapter
Cite this chapter
Friede, R.L. (1975). Metachromatic Leukodystrophy (Sulfatase A Deficiency) and Multiple Sulfatase Deficiency. In: Developmental Neuropathology. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3338-5_38
Download citation
DOI: https://doi.org/10.1007/978-3-7091-3338-5_38
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-3340-8
Online ISBN: 978-3-7091-3338-5
eBook Packages: Springer Book Archive